Maia Wealth
ABBV icon

Maia Wealth’s AbbVie ABBV Stock Holding History

Maia Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$520K Sell
1,989
-243
-11% -$62.3K 0.07% 210
2026
Q2 		$562K Sell
2,232
-423
-16% -$91K 0.08% 210
2026
Q1 		$578K Buy
2,655
+119
+5% +$26.4K 0.1% 200
2025
Q4 		$577K Sell
2,536
-235
-8% -$53.5K 0.1% 200
2025
Q3 		$606K Sell
2,771
-342
-11% -$69.6K 0.1% 188
2025
Q2 		$578K Buy
3,113
+67
+2% +$12.5K 0.11% 181
2025
Q1 		$546K Buy
3,046
+163
+6% +$31.7K 0.12% 165
2024
Q4 		$510K Sell
2,883
-78
-3% -$14.3K 0.11% 163
2024
Q3 		$562K Buy
2,961
+142
+5% +$26.5K 0.14% 137
2024
Q2 		$474K Buy
+2,819
New +$467K 0.14% 126
2023
Q4 		$424K Buy
+2,739
New +$399K 0.17% 119

Other funds holding ABBV

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Maia Wealth's ABBV Position: Q3 2026 in Review

Maia Wealth reduced its AbbVie (ABBV) stake by 11% in Q3 2026, selling an estimated $62.3K and leaving 1,989 shares worth $520K. The position accounts for 0.07% of the portfolio, ranked #210.

Maia Wealth first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $606K in Q3 2025. 3,691 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Maia Wealth held 1,989 shares of AbbVie worth $520K as of Q3 2026.
  • Maia Wealth sold 243 AbbVie shares in Q3 2026, an estimated $62.3K.
  • AbbVie made up 0.07% of Maia Wealth's portfolio in Q3 2026, its #210 holding.
  • Maia Wealth first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • Maia Wealth's AbbVie position peaked at $606K in Q3 2025.
  • 3,691 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Maia Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.